Advertisement

Topics

Cholestech Company Profile

12:49 EST 21st November 2017 | BioPortfolio

Cholestech Corporation develops, manufactures and markets a proprietary platform technology -- the Cholestech L.D.X(R) System -- whose first applications in the preventive care market measure specific analytes to detect various diseases and disorders within five minutes using a single drop of whole blood. The Company currently markets its Cholestech L.D.XSystem and a series of lipid and glucose panels for diagnostic screening and therapeutic monitoring applications. In January 1996, the Cholestech L.D.X System and the Company's total cholesterol, high density lipoproteins, triglycerides and glucose tests were granted waived status under the Clinical Laboratory Improvement Amendments of 1988, the first such waiver granted under Clinical Laboratory Improvement Amendments of 1988's newly-developed ease of

use, accuracy and precision guidelines. The Clinical Laboratory Improvement Amendments of 1988 waiver allows health care providers to use the Cholestech L.D.X System without the additional operating costs and extensive regulatory

requirements associated with Clinical Laboratory Improvement Amendments of 1988 compliance. The Company believes that the Cholestech L.D.X System is the only multi-analyte diagnostic system to be classified as waived under Clinical

Laboratory Improvement Amendments of 1988. The Company believes that the Cholestech L.D.X System's Clinical Laboratory Improvement Amendments of 1988 waived status, technological flexibility, ease of use, accuracy and low

maintenance costs provide it with competitive advantages over other preventive care diagnostic systems.

Location

3347 Investment Boulevard
Hayward
CA
94545
United States of America

Contact

Phone: 510 732 7200
Fax: 510 732 7227
Email: ctec_pr@cholestech.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR)

This is a multi-center study designed to assess the accuracy and precision of the Cholestech LDX Cardiac hsCRP test for the quantitative determination of C-reactive protein (CRP) in whole ...

Companies [1 Associated Companies listed on BioPortfolio]

Cholestech

Cholestech Corporation develops, manufactures and markets a proprietary platform technology -- the Cholestech L.D.X(R) System -- whose first applications in the preventive care market measure spe...

More Information about "Cholestech" on BioPortfolio

We have published hundreds of Cholestech news stories on BioPortfolio along with dozens of Cholestech Clinical Trials and PubMed Articles about Cholestech for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cholestech Companies in our database. You can also find out about relevant Cholestech Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record